IRADIMED CORPORATION Announces Changes to its Board of Directors
March 29 2016 - 4:00PM
IRADIMED CORPORATION (NASDAQ:IRMD), today announced that
Anthony Vuoto has been appointed to the company’s Board of
Directors and that Jim Hawkins, Chairman of the Board will not
stand for re-election at the company’s upcoming Annual Meeting of
Stockholders.
Mr. Vuoto, 64, is a recently retired General Manager of Retail
Payment Solutions at US Bank. Throughout his career, Mr.
Vuoto has held senior leadership positions in a number of financial
institutions and has focused on operations, treasury, investor
relations, business development, financial planning and
reporting. In addition to being appointed to serve as a Board
member, Mr. Vuoto will also serve as a member of the Audit
Committee and the Chairman of the Compensation Committee.
“I am pleased to welcome Tony to the Board of Directors,” said
Roger Susi, President and Chief Executive Officer of the
company. “Tony is an experienced leader with deep knowledge
in a number of strategic and organizational areas. We look
forward to working closely with him and benefiting from his varied
experiences,” said Susi.
IRADIMED also announced today that Jim Hawkins, a member of the
Board of Directors since 2005 and serving as Chairman since 2013,
will not stand for re-election to the company’s Board of Directors
at the upcoming 2016 Annual Meeting of Stockholders. Mr.
Hawkins will continue in his role as Chairman until our 2016 Annual
Meeting of Stockholders. Subsequently, Mr. Hawkins will
remain involved with the company through the establishment of an
advisory board and provide guidance on business development and
strategic matters. Mr. Susi will be nominated as Chairman of
the Board at the Annual Meeting of Stockholders.
“Jim has provided valuable insight and leadership to me and the
management team during his tenure as Chairman and prior to that as
a member of the board these past 12 years. Although stepping
away from the Board, Jim will remain involved with IRADIMED through
the establishment of an advisory board where he will maintain his
mentorship on strategic matters,” said Susi.
About IRADIMED CORPORATION
IRADIMED CORPORATION is the only known provider of
non-magnetic intravenous (IV) infusion pump systems that are
specifically designed to be safe for use during magnetic resonance
imaging (MRI) procedures. We were the first to develop an infusion
delivery system that largely eliminates many of the dangers and
problems present during MRI procedures. Standard infusion pumps
contain magnetic and electronic components which can create radio
frequency (RF) interference and are dangerous to operate in the
presence of the powerful magnet that drives an MRI system. Our
patented MRidium MRI compatible IV infusion pump system has been
designed with a non-magnetic ultrasonic motor, uniquely-designed
non-ferrous parts and other special features in order to safely and
predictably deliver anesthesia and other IV fluids during various
MRI procedures. Our pump solution provides a seamless approach that
enables accurate, safe and dependable fluid delivery before, during
and after an MRI scan, which is important to critically-ill
patients who cannot be removed from their vital medications, and
children and infants who must generally be sedated in order to
remain immobile during an MRI scan.
MRidium is a trademark of IRADIMED CORPORATION.
For more information please visit www.iradimed.com.
Media Contact:
Chris Scott
Chief Financial Officer
IRADIMED CORPORATION
(407) 677-8022
InvestorRelations@iradimed.com
iRadimed (NASDAQ:IRMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
iRadimed (NASDAQ:IRMD)
Historical Stock Chart
From Jul 2023 to Jul 2024